Exploring the Prevalence and Patterns of Valvular Lesions in Rheumatic Heart Disease: Insights from South Indian Cohort
Abstract
Rheumatic heart disease (RHD) continues to pose a considerable public health challenge globally, impacting approximately 40 million individuals, as reported by the World Health Organization. Present study intended to measure the spectrum of valvular lesions in patients with rheumatic heart disease (RHD) using echocardiography among a South Indian Cohort. A total of 216 patients from Dhanya Cardiac Center, Salem, South india were enrolled, with a mean age of 43.7 years and a median age of 43 years. The majority of patients (64.4%) were between 31 and 60 years old, and 61.6% were female. Nearly all patients (92.6%) had a history of rheumatic fever. Valvular stenosis was observed in 92.6% of the patients, with mitral stenosis being the predominant type at 90.3%, followed by aortic stenosis (10.2%) and tricuspid stenosis (0.5%). Additionally, 99.1% of patients exhibited valvular regurgitation, predominantly mitral regurgitation (97.2%), with aortic regurgitation seen in 72.7%. The severity of mitral regurgitation ranged from mild (60.6%) to severe (5.1%), while 42.1% of patients had mild aortic regurgitation. These findings underscore the significant burden of mitral valve involvement in RHD and highlight the need for targeted interventions in this population. The study adds to the understanding of regional variations in RHD presentation and suggests avenues for future research focused on optimizing diagnostic and therapeutic approaches.
Keywords:
Aortic Regurgitation, Echocardiography, Mitral StenosisDOI
https://doi.org/10.25004/References
Roadmap for access to medicines, vaccines and health product 2019-2023. Comprehensive support for access to medicines, vaccines and other health products. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
Negi PC, Sondhi S, Asotra S, Mahajan K, Mehta A. Current status of rheumatic heart disease in India. Indian Heart J. 2019 Jan-Feb;71(1):85-90. doi: 10.1016/j.ihj.2018.12.007. Epub 2019 Jan 4. PMID: 31000189; PMCID: PMC6477130.
Dass C, Kanmanthareddy A. Rheumatic Heart Disease. [Updated 2023 Jul 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538286.
Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL. Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013; 14:611-644.
Alam MS, Rahman MA, Karim MF, Khatun K, Hye MA, Munira S, Raha SK, Biswas SK, Jobayer M. Spectrum of valvular lesions in newly diagnosed rheumatic heart disease. International Journal of Research in Medical Sciences. 2023; 11(9), p.3239.
Ali AM, Packer EJ, Omdal TR, Kitsou V, Urheim S, Saeed S. Echocardiography assessment of rheumatic heart disease: implications for percutaneous balloon mitral valvuloplasty. Current Problems in Cardiology. 2023; p.102021.
Arjun M, Rajasekhar D, Mohan A, Chandra A, Devi BV, Sangaraju SL. Clinical Presentation and Pattern of Cardiac Involvement in Patients with Rheumatic Heart Disease: A Prospective Observational Study. Journal of the Practice of Cardiovascular Sciences. 2023; 9(2), pp.116-120.
Berhanu H, Mossie A, Morankar SN, Gemechu TD, Tegene E. Echocardiographic Parameters and Complication Profiles Among Adult Patients with Rheumatic Heart Disease at Jimma Medical Center. Vascular Health and Risk Management. 2024; pp.157-166.
Lamichhane P, Patel F, Al Mefleh R, Gasimelseed SY, Ala A, Gawad G, Soni S. Detection and management of latent rheumatic heart disease: a narrative review. Annals of Medicine and Surgery. 2024; 85(12), pp.6048-6056.
Pandian NG, Kim JK, Arias-Godinez JA, Marx GR, Michelena HI, Mohan JC. Ogunyankin. Recommendations for the use of echocardiography in the evaluation of rheumatic heart disease: a report from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2023; 36(1), pp.3-28.
Regmi PR, Adhikaree A, Bhattarai U, Chhetri S, Shakya U, Uranw S, Lamichhane P, Sharma SK. Rheumatic heart disease in school-attending Nepalese children: A descriptive analysis of the national heart screening database. Indian Heart Journal. 2023; 75(5), pp.363-369.
Rwebembera J, Marangou J, Mwita JC, Mocumbi AO, Mota C, Okello E. Nascimento B, Thorup L, Beaton A, Kado J, Kaethner A. World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nature Reviews Cardiology. 2024; 21(4), pp.250-263.
Topçu S, Uçar, T. Echocardiographic Screening of Rheumatic Heart Disease: Current Concepts and Challenges. Turkish Archives of Pediatrics. 2024; 59(1), p.3.
Williamson J, Remenyi B, Francis J, Morris P, Whalley G. Echocardiographic Screening for Rheumatic Heart Disease: A Brief History and Implications for the Future. Heart, Lung and Circulation. 2024; Volume 33, Issue 7 p 943-950.
Sika-Paotonu D, Beaton A, Raghu A, et al. Acute Rheumatic Fever and Rheumatic Heart Disease. 2017 Mar 10 [Updated 2017 Apr 3]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center. 2016; Available from: https://www.ncbi.nlm.nih.gov/books/NBK425394.
Passos LSA, Nunes MCP, Aikawa E. Rheumatic Heart Valve Disease Pathophysiology and Underlying Mechanisms. Front Cardiovasc Med. 2021 Jan 18; 7:612716. doi: 10.3389/fcvm.2020.612716. PMID: 33537348; PMCID: PMC7848031.
Published

How to Cite
Issue
Section
Copyright (c) 2025 Dr. Shivapriya NR, Dr. B. Senthil Kumar, Dr. Sakkarai Jayagandhi, Dr. Sangeetha

This work is licensed under a Creative Commons Attribution 4.0 International License.